Genedrive PLC Director/PDMR Shareholding (2148H)
April 04 2022 - 12:13PM
UK Regulatory
TIDMGDR
RNS Number : 2148H
Genedrive PLC
04 April 2022
Notification and public disclosure of transactions by persons
discharging
managerial responsibilities and persons closely associated with
them
genedrive plc (LSE: GDR) ("genedrive" or the "Company"), the
near patient molecular diagnostics company, announces the following
transaction by PDMRs.
The Company has granted share options ("Options") to Russell
Shaw, CFO Designate and a PDMR, to acquire a total of 100,000
ordinary shares of 1.5p each ("Ordinary Shares") in the Company
under the Company's Share Option Scheme.
The Options have been granted with an exercise price of 30p per
share equating to the closing price on the day before the grant and
vest after a period of three years, subject to certain performance
criteria being met through achieving revenue targets, achieving
cash targets and completing certain strategic projects in the year
ending June 2024. The Options are exercisable over the period of 10
years from the date of grant.
In addition, Matthew Fowler, outgoing CFO and a PDMR, has today
exercised 264,046 Options over Ordinary Shares at a price of 30.5p
and following this exercise he subsequently sold 264,046 Ordinary
Shares at a price of 36.5p per share. Following the above
transaction Matthew Fowler has an interest in 52,500 Ordinary
Shares.
Application has been made for 264,046 Ordinary Shares to be
admitted to trading on AIM ("Admission"). Admission is expect to
occur on 8 April 2022 and the Ordinary Shares will, on issue, rank
pari passu in all respects with the Company's existing Ordinary
Shares.
On Admission, the Company will have a total of 92,534,946
Ordinary Share in issue. No Ordinary Shares are held in treasury.
The figure of 92,534,946 may be used by the Company's shareholders
as the denominator in the calculations by which they will determine
if they are required to notify their interest in, or a change to
their interest in, the Company under the Financial Conduct
Authority's Disclosure, Guidance and Transparency Rules.
The information set out below is provided in accordance with the
requirements of Article 19(3) of the EU Market Abuse Regulation No
596/2014.
1. Details of the person discharging managerial responsibilities
/ person closely associated
a. Name 1. Russell Shaw
----------------------- -----------------------------------------------
2. Reason for the notification
------------------------------------------------------------------------
a. Position/status 1. CFO Designate
----------------------- -----------------------------------------------
a. Initial notification Initial notification
/Amendment
----------------------- -----------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
------------------------------------------------------------------------
a. Name genedrive plc
----------------------- -----------------------------------------------
b. LEI 213800ZYODIRZ87Y4K14
----------------------- -----------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
------------------------------------------------------------------------
a. Description Options over ordinary shares of 1.5 pence
of the each
Financial instrument,
type
of instrument
Identification GB00B1VKB244
code
----------------------- -----------------------------------------------
b. Nature of the Grant of options pursuant to and in accordance
transaction with the terms of the Company's Share Option
Scheme dated 29 November 2017
----------------------- -----------------------------------------------
c. Price(s) and
volume(s)
Option price(s) Volume(s)
30p 100,000
----------
----------------------- -----------------------------------------------
d. Aggregated
information N/A
Aggregated
volume
Price
----------------------- -----------------------------------------------
e. Date of the 2022-04-04
transaction
----------------------- -----------------------------------------------
f. Place of the Outside a trading venue
transaction
----------------------- -----------------------------------------------
1. Details of the person discharging managerial responsibilities
/ person closely associated
a. Name 1. Matthew Fowler
----------------------- ----------------------------------------------------
2. Reason for the notification
-----------------------------------------------------------------------------
a. Position/status 1. Outgoing CFO
----------------------- ----------------------------------------------------
a. Initial notification Initial notification
/Amendment
----------------------- ----------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-----------------------------------------------------------------------------
a. Name genedrive plc
----------------------- ----------------------------------------------------
b. LEI 213800ZYODIRZ87Y4K14
----------------------- ----------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-----------------------------------------------------------------------------
a. Description Exercise of Options over ordinary shares
of the of 1.5 pence each and sale of ordinary shares
Financial instrument, of 1.5p each
type
of instrument
Identification
code GB00B1VKB244
----------------------- ----------------------------------------------------
b. Nature of the Exercise of options pursuant to and in accordance
transaction with the terms of the Company's Share Option
Scheme dated 29 November 2017 and subsequent
sale of ordinary shares
----------------------- ----------------------------------------------------
c. Price(s) and
volume(s)
Option exercise price No. of options exercised
30.5p 264,046
-------------------------
Sale price No. of ordinary shares
sold
36.5p 264,046
-----------------------
----------------------- ----------------------------------------------------
d. Aggregated
information Gross proceeds realised of GBP96,376.79
Aggregated
volume
Price
----------------------- ----------------------------------------------------
e. Date of the 2022-04-04
transaction
----------------------- ----------------------------------------------------
f. Place of the Outside a trading venue and Aim for the
transaction disposal
----------------------- ----------------------------------------------------
For further details please contact:
genedrive plc +44 (0)161 989 0245
David Budd: CEO / Matthew Fowler: CFO
Peel Hunt LLP (Nominated Adviser and
Joint Broker) +44 (0)20 7418 8900
James Steel
finnCap (Joint Broker) +44 (0)20 7220 500
Geoff Nash / Kate Bannatyne / Alice
Lane
Walbrook PR Ltd (Media Relations & +44 (0)20 7933 8780 or genedrive@walbrookpr.com
Investor Relations)
+44 (0)7980 541 893 / +44 (0)7876
Paul McManus / Anna Dunphy 741 001
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHEAKLLEFAAEFA
(END) Dow Jones Newswires
April 04, 2022 12:13 ET (16:13 GMT)
Genedrive (LSE:GDR)
Historical Stock Chart
From Feb 2024 to Mar 2024
Genedrive (LSE:GDR)
Historical Stock Chart
From Mar 2023 to Mar 2024